Brief: CureVac NV Says Cash And Cash Equivalents Position Of €617.5 Mln As Of March 31, 2023
30/05/2023 14:03
May 30 (Reuters) - CureVac NV 5CV.DE :
* CUREVAC NV - CASH AND CASH EQUIVALENTS POSITION OF €617.5
MILLION AS OF MARCH 31, 2023
* CUREVAC NV - REVENUES AMOUNTED TO €7.1 MILLION FOR Q1
2023,
REPRESENTING DECREASE OF €17.3 MILLION
Further company coverage: 5CV.DE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CureVac NV
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Biontech Closes Acquisition Of CureVac
Brief: BioNTech Says CureVac Shareholders Are Advised To Tender Their Shares By 6:00 P.M. Eastern Time On Tuesday, December 2, 2025
Brief: Curevac Reaffirms Its Expected Cash Runway Into 2028